MediFind

Find a Doctor

David F. Claxton

The Milton S Hershey Medical Center Physicians Group
Oncology, Hematology, Internal Medicine
Male
Practicing approx. 42 years
Approx. age 66

Bio


David Claxton is an Internal Medicine specialist and an Oncologist in Hershey, Pennsylvania. He has been an author on 85 peer reviewed articles and participated in 3 clinical trials in the past 15 years. Dr. Claxton's top three areas of expertise are Acute Myeloid Leukemia, Acute Myeloblastic Leukemia with Maturation, and Acute Myeloblastic Leukemia without Maturation. He is licensed to treat patients in PA.

Contact

500 University Dr
Hershey, PA 17033, US

Latest Research


Latest Advance
Study
  • Condition: Elderly Patients with Acute Myeloid Leukemia (AML)
  • Journal: British journal of haematology
  • Treatment Used: Decitabine
  • Number of Patients: 0
  • Published —
This study determined whether defining how decitabine influences the immune responses in acute myeloid leukaemia (AML) will facilitate the development of novel immune-based leukemia therapeutics.
Latest Advance
Study
  • Condition: Chronic Lymphocytic Leukemia
  • Journal: Acta haematologica
  • Treatment Used: Pentostatin, Cyclophosphamide, and Rituximab Followed by Alemtuzumab
  • Number of Patients: 102
  • Published —
In this study, researchers evaluated the outcomes of using pentostatin, cyclophosphamide, and rituximab followed by alemtuzumab for the treatment of relapsed/refractory chronic lymphocytic leukemia.
Latest Advance
Study
  • Condition: Relapsed B-cell Non-hodgkin Lymphoma and Previously Untreated Mantle Cell Lymphoma
  • Journal: British journal of haematology
  • Treatment Used: Vorinostat and Cladribine and Rituximab
  • Number of Patients: 18
  • Published —
In this study, researchers evaluated the effects of vorinostat and cladribine and rituximab on relapsed B-cell non-Hodgkin lymphoma and previously untreated mantle cell lymphoma.
Latest Advance
Study
  • Condition: Acute Lymphoblastic Leukemia
  • Journal: Blood
  • Treatment Used: CALGB10403 Pediatric Regimen
  • Number of Patients: 318
  • Published —
This study tested the safety and efficacy of using the CALGB10403 pediatric regimen to treat patients with acute lymphoblastic leukemia.
Latest Advance
Study
  • Condition: Chronic lymphocytic leukemia
  • Journal: Annals of oncology : official journal of the European Society for Medical Oncology
  • Treatment Used: Ibrutinib, idelalisib, and venetoclax
  • Number of Patients: 683
  • Published —
This study evaluated the optimal sequencing of ibrutinib, idelalisib, and venetoclax in patients with chronic lymphocytic leukemia.

Clinical Trials


All Publications
View All


Contact

500 University Dr
Hershey, PA 17033, US

Affiliations

  • Milton S Hershey Medical Center

Credentials

  • Licenses
    Internal Medicine in PA
  • Board Certifications
    Hematology/oncology

Insurance

Contact them to find out if they accept your insurance plan.